This public procurement record has 2 releases in its history.

Award

12 Aug 2022 at 14:39

Tender

17 Mar 2022 at 15:12

Summary of the contracting process

The public procurement contracting process is currently in the Tender stage. The buying organisation is identified as [Buying Organisation]. The title of the procurement project is [Title], falling under the industry category of [Industry Category]. The location for this procurement is in [Location]. Key dates and deadlines include [Key Dates/Deadlines], providing opportunities for businesses to bid on this contract and grow their operations.

This tender presents an opportunity for businesses in [Industry Category] to compete for a government contract with [Buying Organisation]. Companies specialising in [Specific Business Types] would be well-suited to engage in this procurement process. By participating in this tender, businesses can expand their market reach and establish a valuable partnership with the contracting authority, increasing their growth potential.

How relevant is this notice?

Notice Title

NHS National Pharmaceuticals Transition 2022_1

Notice Description

NHS National Pharmaceuticals Transition 2022_1<br/>Potential periods of call-offs under the<br/>framework agreement:<br/>Transition:<br/>CESW: 29/07/2022 to 30/09/2023 (14<br/>months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6months)<br/>Oral (plus non-parenteral) Products: All<br/>regions: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>Hospital Only Products:<br/>CESW: 29/07/2022 to 30/09/2023 (14<br/>months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22<br/>months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6<br/>months)

Lot Information

Lot 1 - CM/PHG/21/5637/00 Transition products

Invitation to offer for NHS National Pharmaceuticals Transition 2022_1
Offer reference number: CM/PHG/21/5637/00
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.
Potential periods of call-offs under the framework agreement:
Transition: CESW: 29/07/2022 to30/09/2023 (14 months)
LSNE: 29/07/2022 to 31/05/2024 (22months)
NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.

Lot 2 - CM/PHG/21/5637/01 Oral (plus non-parenteral) products

Invitation to offer for NHS National Pharmaceuticals Transition 2022_1
Offer reference number: CM/PHG/21/5637/01
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.
Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.

Lot 3 - CM/PHG/21/5637/02 Hospital Only Products

Invitation to offer for NHS National Pharmaceuticals Transition 2022_1
Offer reference number: CM/PHG/21/5637/02
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.
Hospital Only Products: CESW:29/07/2022 to 30/09/2023 (14 months)
LSNE: 29/07/2022 to 31/05/2024 (22months)
NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-032338
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/022307-2022
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£467,969,000 £100M-£1B
Lots Value
£467,969,000 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
12 Aug 20224 years ago
Submission Deadline
21 Apr 2022Expired
Future Notice Date
Not specified
Award Date
19 Jul 20224 years ago
Contract Period
1 Jul 2022 - 31 May 2024 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS England
Additional Buyers

The NHS Commissioning Board (operating under the name of NHS England)

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Postcode Area
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Supplier Information

Number of Suppliers
42
Supplier Names

Accord-UK Ltd

Alturix

Amarox Limited

Aspen Pharmacare UK Limited

B. Braun Medical Limited

Celix Pharma Ltd.

Chiesi Limited

Clinigen Healthcare Limited

Consilient Health Ltd

Day Lewis Medical Ltd

Dr.Reddy's Laboratories (UK) Limited

FLYNN PHARMA LTD

Flexipharm Austrading Limited

Fresenius Kabi Limited

Glenmark Pharmaceuticals Europe Limited

Intrapharm Laboratories Ltd

Kent Pharma Ltd

Macure Pharma ApS

Mercury Pharmaceuticals Limited

Milpharm Ltd/aurobinbdo

Morningside Pharmaeuticals

Mylan

Napp Pharmaceuticals Ltd

Neon Healthcare Ltd

Norgine Pharmaceuticals Limited

Panpharma UK Limited

Pfizer Ltd

Piramal Critical care Limited

Ranbaxy UK

Relonchem Ltd

Roche Products Ltd

Roma Pharmaceuticals Limited

Rosemont Pharmaceuticals Limited

Sandoz Ltd

Selective Supplies Ltd.

Sintetica Ltd

Teva UK Limited

Tillomed Laboratories ltd

Wockhardt UK Limited

Zentiva Pharma UK Ltd

ennogen healthcare ltd

medac Pharma LLP

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...